Merck KGaA: Karl-Ludwig Kley Named Executive Board Deputy Chairman

15-Mar-2006

The Advisory Board of E.Merck OHG has named Dr. Karl-Ludwig Kley, 54, as deputy chairman of the Merck KGaA Executive Board and general partner of E. Merck OHG, effective September 1, 2006. The appointment is contingent on the termination of Kley's current employment contract with Deutsche Lufthansa AG.

Kley will be responsible for the integration of Schering AG, Berlin. Merck announced earlier its decision to make a public takeover of Schering, offering its shareholders EUR 77 in cash per share.

Kley has been a member of the Executive Board at Deutsche Lufthansa AG since 1998 and a member of the Supervisory Board of Merck KGaA as well as the Advisory Board of E. Merck OHG since 2004. The latter company oversees the 73% stake the Merck family holds in Merck KGaA. Before moving to Lufthansa, Kley held various leadership positions at Bayer AG in Leverkusen, Germany. There he led the pharma business's sales and marketing operations in Africa, Asia and Latin America before taking over responsibility for corporate finance and investor relations. During his time at Bayer, he also spent eight years abroad, in Japan and Italy, Kley completed his law degree in 1979 at the University of Munich and then went on to obtained a PhD.

The position of deputy chairman of the executive board has remained vacant since Dr. Michael Roemer was named chairman of the board in November 2005.

Other news from the department people

Most read news

More news from our other portals

Discover the latest developments in battery technology!